NPPB and Nephropathy: Patients in group C presented a 2.53-fold increase in the risk of kidney damage than those in group A (OR = 2.53, (1.22–5.27, 95% CI), p = 0.014, suggesting that NT-proBNP can serve as an adverse prognostic factor.